Jyong Biotech Ltd. Ordina...

NASDAQ: MENS · Real-Time Price · USD
43.94
2.44 (5.88%)
At close: Aug 19, 2025, 1:46 PM

Jyong Biotech Ordinary Shares Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-2.06M -2.8M -2.83M -2.4M
Interest Income
7K 56K 5K 6K
Pretax Income
-3.02M -4.4M -6.63M -4.2M
Net Income
-3.02M -4.4M -6.63M -4.2M
Selling & General & Admin
1.13M 1.73M 1.54M 845K
Research & Development
927K 1.07M 1.29M 1.56M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
2.06M 2.8M 2.83M 2.4M
Interest Expense
1.03M 757K 765K 835K
Selling & Marketing Expenses
44K 47K 47K 54K
Cost & Expenses
2.06M 2.8M 2.83M 2.4M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
76.03M 76.03M 76.03M 76.03M
Shares Outstanding (Diluted)
76.03M 76.03M 76.03M 76.03M
EPS (Basic)
-0.04 -0.06 -0.09 -0.06
EPS (Diluted)
-0.04 -0.06 -0.09 -0.06
EBITDA
-1.86M -3.52M -5.74M -3.24M
EBIT
-1.98M -3.64M -5.87M -3.36M
Depreciation & Amortization
120K 127K 123K 122K